• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物标志物之间的条件独立性关系可以改善临床决策,例如在三阴性乳腺癌的情况下。

Conditional independence relations among biological markers may improve clinical decision as in the case of triple negative breast cancers.

机构信息

Dipartimento di Statistica G. Parenti, Università degli Studi di Firenze, viale Morgagni 59, Florence, Italy.

出版信息

BMC Bioinformatics. 2009 Oct 15;10 Suppl 12(Suppl 12):S13. doi: 10.1186/1471-2105-10-S12-S13.

DOI:10.1186/1471-2105-10-S12-S13
PMID:19828073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2762062/
Abstract

The associations existing among different biomarkers are important in clinical settings because they contribute to the characterisation of specific pathways related to the natural history of the disease, genetic and environmental determinants. Despite the availability of binary/linear (or at least monotonic) correlation indices, the full exploitation of molecular information depends on the knowledge of direct/indirect conditional independence (and eventually causal) relationships among biomarkers, and with target variables in the population of interest. In other words, that depends on inferences which are performed on the joint multivariate distribution of markers and target variables. Graphical models, such as Bayesian Networks, are well suited to this purpose. Therefore, we reconsidered a previously published case study on classical biomarkers in breast cancer, namely estrogen receptor (ER), progesterone receptor (PR), a proliferative index (Ki67/MIB-1) and to protein HER2/neu (NEU) and p53, to infer conditional independence relations existing in the joint distribution by inferring (learning) the structure of graphs entailing those relations of independence. We also examined the conditional distribution of a special molecular phenotype, called triple-negative, in which ER, PR and NEU were absent. We confirmed that ER is a key marker and we found that it was able to define subpopulations of patients characterized by different conditional independence relations among biomarkers. We also found a preliminary evidence that, given a triple-negative profile, the distribution of p53 protein is mostly supported in 'zero' and 'high' states providing useful information in selecting patients that could benefit from an adjuvant anthracyclines/alkylating agent-based chemotherapy.

摘要

不同生物标志物之间的关联在临床环境中很重要,因为它们有助于描述与疾病自然史、遗传和环境决定因素相关的特定途径。尽管存在二元/线性(或至少单调)相关指数,但要充分利用分子信息,取决于对生物标志物之间以及目标变量在感兴趣人群中的直接/间接条件独立性(最终是因果关系)的了解。换句话说,这取决于对标记和目标变量的联合多变量分布进行的推断。图形模型,如贝叶斯网络,非常适合这个目的。因此,我们重新考虑了先前发表的关于乳腺癌经典生物标志物的案例研究,即雌激素受体(ER)、孕激素受体(PR)、增殖指数(Ki67/MIB-1)以及蛋白 HER2/neu(NEU)和 p53,通过推断(学习)包含这些独立性关系的图形结构,推断(学习)联合分布中存在的条件独立性关系。我们还检查了一种特殊分子表型,称为三阴性,即 ER、PR 和 NEU 均不存在的条件分布。我们证实 ER 是一个关键标志物,并且发现它能够定义具有不同生物标志物之间条件独立性关系的患者亚群。我们还发现了初步证据,表明在给定三阴性特征的情况下,p53 蛋白的分布主要支持在“零”和“高”状态,这为选择可能受益于辅助蒽环类药物/烷化剂化疗的患者提供了有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/a067614fcdb8/1471-2105-10-S12-S13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/2d7dbfa707e5/1471-2105-10-S12-S13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/7d8df1822ab4/1471-2105-10-S12-S13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/ca1bbdab20e5/1471-2105-10-S12-S13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/c4fb7ad0f80d/1471-2105-10-S12-S13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/a067614fcdb8/1471-2105-10-S12-S13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/2d7dbfa707e5/1471-2105-10-S12-S13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/7d8df1822ab4/1471-2105-10-S12-S13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/ca1bbdab20e5/1471-2105-10-S12-S13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/c4fb7ad0f80d/1471-2105-10-S12-S13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5add/2762062/a067614fcdb8/1471-2105-10-S12-S13-5.jpg

相似文献

1
Conditional independence relations among biological markers may improve clinical decision as in the case of triple negative breast cancers.生物标志物之间的条件独立性关系可以改善临床决策,例如在三阴性乳腺癌的情况下。
BMC Bioinformatics. 2009 Oct 15;10 Suppl 12(Suppl 12):S13. doi: 10.1186/1471-2105-10-S12-S13.
2
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.雌激素受体(ER)mRNA 表达与孕激素受体阳性、雌激素受体阴性乳腺癌的分子亚型分布。
Breast Cancer Res Treat. 2014 Jan;143(2):403-9. doi: 10.1007/s10549-013-2763-z. Epub 2013 Dec 15.
3
Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018.2015-2018 年连续四年乳腺癌预测标志物(激素受体、Her2、Ki67)和内在亚型的变异性。
J Cancer Res Clin Oncol. 2019 Dec;145(12):2983-2994. doi: 10.1007/s00432-019-03057-0. Epub 2019 Oct 18.
4
Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.乳腺癌中 BRCA1 蛋白、ER、PR 和 Her2/neu 的免疫组织化学表达:一项临床病理研究。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1025-1029. doi: 10.31557/APJCP.2020.21.4.1025.
5
Association of Histopathological Markers with Clinico- Pathological Factors in Mexican Women with Breast Cancer.墨西哥乳腺癌女性组织病理学标志物与临床病理因素的关联
Asian Pac J Cancer Prev. 2015;16(18):8397-403. doi: 10.7314/apjcp.2015.16.18.8397.
6
Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.筛查检出浸润性乳腺癌与症状性浸润性乳腺癌亚型分布的差异及其对生存的影响。
Clin Transl Oncol. 2017 Oct;19(10):1232-1240. doi: 10.1007/s12094-017-1660-z. Epub 2017 Apr 13.
7
Triple-negative breast cancer: current state of the art.三阴性乳腺癌:当前的技术水平
Tumori. 2010 Nov-Dec;96(6):875-88.
8
Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.乳腺癌中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER-2/neu,即C-erb B 2)反应模式与组织学分级、肿瘤大小及淋巴结状态的比较
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.
9
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.miRNA 特征可预测乳腺癌中雌激素受体、孕激素受体和 HER2/neu 受体状态。
Breast Cancer Res. 2009;11(3):R27. doi: 10.1186/bcr2257. Epub 2009 May 11.
10
Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.使用来自妇女健康倡议(WHI)观察性研究的临床前血浆鉴定出的雌激素受体阳性/孕激素受体阳性浸润性导管癌的候选早期检测蛋白质生物标志物。
Breast Cancer Res Treat. 2015 Sep;153(2):445-54. doi: 10.1007/s10549-015-3554-5. Epub 2015 Aug 30.

引用本文的文献

1
Chain graph models to elicit the structure of a Bayesian network.用于引出贝叶斯网络结构的链图模型。
ScientificWorldJournal. 2014 Feb 5;2014:749150. doi: 10.1155/2014/749150. eCollection 2014.

本文引用的文献

1
Triple-negative breast cancer: clinical features and patterns of recurrence.三阴性乳腺癌:临床特征与复发模式
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34. doi: 10.1158/1078-0432.CCR-06-3045.
2
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.免疫组化标志物的应用可改善三阴性乳腺癌的预后。
BMC Cancer. 2007 Jul 24;7:134. doi: 10.1186/1471-2407-7-134.
3
Triple-negative breast cancer: therapeutic options.三阴性乳腺癌:治疗选择
Lancet Oncol. 2007 Mar;8(3):235-44. doi: 10.1016/S1470-2045(07)70074-8.
4
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.转移性疾病女性患者中乳腺癌分子亚型与紫杉醇反应及预后的关系:CALGB 9342研究结果
Breast Cancer Res. 2006;8(6):R66. doi: 10.1186/bcr1622.
5
Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks.通过贝叶斯网络整合临床和微阵列数据预测乳腺癌的预后。
Bioinformatics. 2006 Jul 15;22(14):e184-90. doi: 10.1093/bioinformatics/btl230.
6
Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.利用并行聚类方法从传统肿瘤标志物谱对乳腺癌进行分子亚型分类。
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):781-90. doi: 10.1158/1078-0432.CCR-05-0763.
7
Prediction of cancer outcome with microarrays.
Lancet. 2005;365(9472):1683; author reply 1684-5. doi: 10.1016/S0140-6736(05)66537-3.
8
Understanding tuberculosis epidemiology using structured statistical models.使用结构化统计模型理解结核病流行病学。
Artif Intell Med. 2004 Mar;30(3):233-56. doi: 10.1016/j.artmed.2003.11.003.
9
Bayesian networks in biomedicine and health-care.生物医学与医疗保健中的贝叶斯网络。
Artif Intell Med. 2004 Mar;30(3):201-14. doi: 10.1016/j.artmed.2003.11.001.
10
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.从乳腺癌细针穿刺活检获得的基因表达谱能够可靠地识别常规预后标志物,并揭示雌激素受体阴性和雌激素受体阳性肿瘤之间的大规模分子差异。
Clin Cancer Res. 2003 Jul;9(7):2406-15.